---
title: "JEI plans to raise no more than 2 billion yuan through a private placement of stocks"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/253244123.md"
description: "According to the Zhitong Finance APP, JEI has announced a plan for a private placement of shares in 2025, with the total amount of funds raised not exceeding 2 billion yuan (including the principal). The net proceeds from the fundraising, after deducting issuance costs, are intended to be invested in the Xibaipo Power Plant Phase IV project"
datetime: "2025-08-15T14:51:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/253244123.md)
  - [en](https://longbridge.com/en/news/253244123.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/253244123.md)
generator: "portal-rs"
---

# JEI plans to raise no more than 2 billion yuan through a private placement of stocks

According to the Zhitong Finance APP, JEI (000600.SZ) has announced a plan to issue shares to specific targets for the year 2025. The total amount of funds raised from this issuance will not exceed 2 billion yuan (including the principal), and the net amount of funds raised after deducting issuance costs is intended to be invested in the Xibaipo Power Plant Phase IV project

### Related Stocks

- [000600.CN](https://longbridge.com/en/quote/000600.CN.md)

## Related News & Research

- [California helicopter maker wins major role in US Army pilot training](https://longbridge.com/en/news/296642218.md)
- [Alex Jones gets Sandy Hook family's Texas verdict reduced on appeal](https://longbridge.com/en/news/296643067.md)
- [Bure Equity announces January–June 2026 interim report video release](https://longbridge.com/en/news/296444969.md)
- [JD Sports cuts profit forecast as Régis Shultz turnaround slows](https://longbridge.com/en/news/296443354.md)
- [Tvardi Therapeutics: TTI-109 targets STAT3 to address unmet needs in UC with selective immune modulation and safety](https://longbridge.com/en/news/296374826.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**